These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

446 related items for PubMed ID: 28502725

  • 1. Molecular Diagnosis of Mosaic Overgrowth Syndromes Using a Custom-Designed Next-Generation Sequencing Panel.
    Chang F, Liu L, Fang E, Zhang G, Chen T, Cao K, Li Y, Li MM.
    J Mol Diagn; 2017 Jul; 19(4):613-624. PubMed ID: 28502725
    [Abstract] [Full Text] [Related]

  • 2. Overgrowth Syndromes Caused by Somatic Variants in the Phosphatidylinositol 3-Kinase/AKT/Mammalian Target of Rapamycin Pathway.
    Akgumus G, Chang F, Li MM.
    J Mol Diagn; 2017 Jul; 19(4):487-497. PubMed ID: 28502730
    [Abstract] [Full Text] [Related]

  • 3. Molecular diagnosis of somatic overgrowth conditions: A single-center experience.
    Lalonde E, Ebrahimzadeh J, Rafferty K, Richards-Yutz J, Grant R, Toorens E, Marie Rosado J, Schindewolf E, Ganguly T, Kalish JM, Deardorff MA, Ganguly A.
    Mol Genet Genomic Med; 2019 Mar; 7(3):e536. PubMed ID: 30761771
    [Abstract] [Full Text] [Related]

  • 4. Clinical delineation and natural history of the PIK3CA-related overgrowth spectrum.
    Keppler-Noreuil KM, Sapp JC, Lindhurst MJ, Parker VE, Blumhorst C, Darling T, Tosi LL, Huson SM, Whitehouse RW, Jakkula E, Grant I, Balasubramanian M, Chandler KE, Fraser JL, Gucev Z, Crow YJ, Brennan LM, Clark R, Sellars EA, Pena LD, Krishnamurty V, Shuen A, Braverman N, Cunningham ML, Sutton VR, Tasic V, Graham JM, Geer J, Henderson A, Semple RK, Biesecker LG.
    Am J Med Genet A; 2014 Jul; 164A(7):1713-33. PubMed ID: 24782230
    [Abstract] [Full Text] [Related]

  • 5. Fibroadipose hyperplasia versus Proteus syndrome: segmental overgrowth with a mosaic mutation in the PIK3CA gene.
    Youssefian L, Vahidnezhad H, Baghdadi T, Ghaznavi A, Li Q, Tabrizi M, Uitto J.
    J Invest Dermatol; 2015 May; 135(5):1450-1453. PubMed ID: 25602158
    [No Abstract] [Full Text] [Related]

  • 6. Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha (PIK3CA)-related overgrowth spectrum: A brief report.
    Denorme P, Morren MA, Hollants S, Spaepen M, Suaer K, Zutterman N, Labarque V, Legius E, Brems H.
    Pediatr Dermatol; 2018 May; 35(3):e186-e188. PubMed ID: 29493003
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, Mirzaa G, Graham JM, Keppler-Noreuil K.
    ; 1993 May. PubMed ID: 23946963
    [Abstract] [Full Text] [Related]

  • 11. Klippel-Trenaunay syndrome belongs to the PIK3CA-related overgrowth spectrum (PROS).
    Vahidnezhad H, Youssefian L, Uitto J.
    Exp Dermatol; 2016 Jan; 25(1):17-9. PubMed ID: 26268729
    [Abstract] [Full Text] [Related]

  • 12. Somatic frameshift mutation in PIK3CA causes CLOVES syndrome by provoking PI3K/AKT/mTOR pathway.
    Yan W, Zhang B, Wang H, Mo R, Jiang X, Qin W, Ma L, Lin Z.
    Hereditas; 2021 Jun 01; 158(1):18. PubMed ID: 34074347
    [Abstract] [Full Text] [Related]

  • 13. Molecular characterization of 13 patients with PIK3CA-related overgrowth spectrum using a targeted deep sequencing approach.
    de Kock L, Cuillerier A, Gillespie M, Couse M, Hartley T, Mears W, Bernier FP, Chudley AE, Frosk P, Nikkel SM, Innes AM, Lauzon J, Thomas M, Guerin A, Armour CM, Weksberg R, Scott JN, Watkins D, Harvey S, Cytrynbaum C, Care4Rare Canada ConsortiumChildren's Hospital of Eastern Ontario Research Institute, Ottawa, Ontario, Canada., Kernohan KD, Boycott KM.
    Am J Med Genet A; 2024 Mar 01; 194(3):e63466. PubMed ID: 37949664
    [Abstract] [Full Text] [Related]

  • 14. Causal somatic mutations in urine DNA from persons with the CLOVES subgroup of the PIK3CA-related overgrowth spectrum.
    Michel ME, Konczyk DJ, Yeung KS, Murillo R, Vivero MP, Hall AM, Zurakowski D, Adams D, Gupta A, Huang AY, Chung BHY, Warman ML.
    Clin Genet; 2018 May 01; 93(5):1075-1080. PubMed ID: 29231959
    [Abstract] [Full Text] [Related]

  • 15. Megalencephaly syndromes: exome pipeline strategies for detecting low-level mosaic mutations.
    Tapper WJ, Foulds N, Cross NC, Aranaz P, Score J, Hidalgo-Curtis C, Robinson DO, Gibson J, Ennis S, Temple IK, Collins A.
    PLoS One; 2014 May 01; 9(1):e86940. PubMed ID: 24497998
    [Abstract] [Full Text] [Related]

  • 16. A case of congenital lipomatous overgrowth, vascular malformations, epidermal nevi, spinal/skeletal anomalies and/or scoliosis syndrome with lipoatrophy as an important clinical manifestation.
    Schreiber A, Grenier PO, Auger I.
    Pediatr Dermatol; 2017 Nov 01; 34(6):735-736. PubMed ID: 28833506
    [Abstract] [Full Text] [Related]

  • 17. Cloves syndrome: a case report and perinatal diagnostic findings.
    Puvabanditsin S, Memon N, Chekmareva M, Di Stefano V, Mehta R.
    Genet Couns; 2014 Nov 01; 25(3):265-70. PubMed ID: 25365848
    [Abstract] [Full Text] [Related]

  • 18. Clinical and Genetic Aspects of the Segmental Overgrowth Spectrum Due to Somatic Mutations in PIK3CA.
    Kang HC, Baek ST, Song S, Gleeson JG.
    J Pediatr; 2015 Nov 01; 167(5):957-62. PubMed ID: 26340871
    [No Abstract] [Full Text] [Related]

  • 19. Segmental overgrowth syndrome due to an activating PIK3CA mutation identified in affected muscle tissue by exome sequencing.
    Rasmussen M, Sunde L, Weigert KP, Bogaard PW, Lildballe DL.
    Am J Med Genet A; 2014 May 01; 164A(5):1318-21. PubMed ID: 24665065
    [Abstract] [Full Text] [Related]

  • 20. [CLOVES syndrome: a malformational syndrome closely resembling Proteus syndrome].
    Guillet A, Aubert H, Tessier MH, David A, Perret C, Penhoat M, Stalder JF, Barbarot S.
    Ann Dermatol Venereol; 2014 May 01; 141(8-9):507-13. PubMed ID: 25209813
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.